Takeda Pharmaceutical Company Limited (4502.T) JPX

5,166.00

+16(+0.31%)

Updated at January 15 09:49AM

Currency In JPY

Valuation

Market Cap6.97T
Enterprise Value11.82T
P/E Ratio245.62
PEG Ratio-3.27
Price/Sales Ratio1.84
Price/Book Ratio1.14
Enterprise/Revenue2.74
Enterprise/EBITDA10.63

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.1

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue4.58T
Revenue/Share2,800.06
Gross Profit2.46T
EBITDA1.13T
Net Income107.93B
Diluted EPS67.23

Balance Sheet

Total Cash739.68B
Total Cash/Share468.9
Total Debt4.65T
Total Debt/Equity0.65
Current Ratio1.36
Book Value Per Share4,520.98

Price History

52-Week Change24.97
52-Week High5,196
52-Week Low3,916
Moving Average 50 Days4,559.7
Moving Average 200 Days4,385.06

Statistics

Average Volume4.52M
Shares Outstanding1.58B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate198
Trailing Annual Dividend Yield3.84
Payout Ratio9.35
Last Split FactorN/A
Last Split DateN/A